Paul Dossa

Paul Dossa is an Investor at Venrock based in the New York City Metropolitan Area, where he focuses on funding disruptive early-stage technology startups. He holds a PhD from The Rockefeller University, which he completed in 2013, providing him with a highly specialized foundation in scientific research and analysis. Prior to entering the venture capital industry, Dossa conducted extensive research at the Sloan Kettering Institute and participated in the Tri-Institutional Training Program in Chemical Biology. In his current investment capacity, he leverages this deep academic expertise to evaluate emerging technology companies, maintaining a professional network of 362 connections and backing ventures such as Seed Pharmaceuticals. His professional trajectory bridges the gap between complex chemical biology research and institutional venture capital. Dossa currently centers his investment strategy on the commercialization and scaling of advanced scientific technologies.